Appili Therapeutics Statistics

Total Valuation

TSX:APLI has a market cap or net worth of CAD 3.64 million. The enterprise value is 14.74 million.

Market Cap	3.64M
Enterprise Value	14.74M

Important Dates

The next estimated earnings date is Thursday, June 26, 2025.

Earnings Date	Jun 26, 2025
Ex-Dividend Date	n/a

Share Statistics

TSX:APLI has 121.27 million shares outstanding. The number of shares has increased by 0.03% in one year.

Current Share Class	n/a
Shares Outstanding	121.27M
Shares Change (YoY)	+0.03%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.06%
Owned by Institutions (%)	n/a
Float	106.83M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	29.16
PB Ratio	-0.27
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-3.72
EV / Sales	118.13
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-23.60

Financial Position

The company has a current ratio of 0.14

Current Ratio	0.14
Quick Ratio	0.13
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-18.07
Interest Coverage	-3.74

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-306.73%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	77.78%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	9
Asset Turnover	0.06
Inventory Turnover	n/a

Taxes

In the past 12 months, TSX:APLI has paid 69,584 in taxes.

Income Tax	69,584
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -37.50% in the last 52 weeks. The beta is 1.08, so TSX:APLI's price volatility has been similar to the market average.

Beta (5Y)	1.08
52-Week Price Change	-37.50%
50-Day Moving Average	0.03
200-Day Moving Average	0.03
Relative Strength Index (RSI)	38.28
Average Volume (20 Days)	62,727

Short Selling Information

The latest short interest is 12,229, so 0.01% of the outstanding shares have been sold short.

Short Interest	12,229
Short Previous Month	47,047
Short % of Shares Out	0.01%
Short % of Float	0.01%
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TSX:APLI had revenue of CAD 124,746 and -3.96 million in losses. Loss per share was -0.03.

Revenue	124,746
Gross Profit	124,746
Operating Income	-9.97M
Pretax Income	-3.96M
Net Income	-3.96M
EBITDA	-9.95M
EBIT	-9.97M
Loss Per Share	-0.03

Full Income Statement

Balance Sheet

The company has 186,166 in cash and 11.28 million in debt, giving a net cash position of -11.10 million or -0.09 per share.

Cash & Cash Equivalents	186,166
Total Debt	11.28M
Net Cash	-11.10M
Net Cash Per Share	-0.09
Equity (Book Value)	-13.63M
Book Value Per Share	-0.11
Working Capital	-12.84M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -622,106 and capital expenditures -2,360, giving a free cash flow of -624,466.

Operating Cash Flow	-622,106
Capital Expenditures	-2,360
Free Cash Flow	-624,466
FCF Per Share	-0.01

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-7,990.47%
Pretax Margin	-3,171.28%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TSX:APLI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.03%
Shareholder Yield	-0.03%
Earnings Yield	-108.75%
FCF Yield	-17.17%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TSX:APLI has an Altman Z-Score of -70.96 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-70.96
Piotroski F-Score	4